- Home
- PKE vs VALN Comparison
PKE vs VALN Comparison
Compare PKE & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PKE
- VALN
- Stock Information
- Founded
- PKE 1954
- VALN 2012
- Country
- PKE United States
- VALN France
- Employees
- PKE N/A
- VALN N/A
- Industry
- PKE Military/Government/Technical
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PKE Industrials
- VALN Health Care
- Exchange
- PKE Nasdaq
- VALN Nasdaq
- Market Cap
- PKE 297.8M
- VALN 354.8M
- IPO Year
- PKE N/A
- VALN 2021
- Fundamental
- Price
- PKE $14.71
- VALN $5.65
- Analyst Decision
- PKE
- VALN Strong Buy
- Analyst Count
- PKE 0
- VALN 2
- Target Price
- PKE N/A
- VALN $17.50
- AVG Volume (30 Days)
- PKE 59.8K
- VALN 50.9K
- Earning Date
- PKE 01-14-2025
- VALN 03-20-2025
- Dividend Yield
- PKE 3.40%
- VALN N/A
- EPS Growth
- PKE N/A
- VALN N/A
- EPS
- PKE 0.36
- VALN N/A
- Revenue
- PKE $61,420,000.00
- VALN $176,817,979.00
- Revenue This Year
- PKE N/A
- VALN $24.66
- Revenue Next Year
- PKE N/A
- VALN $9.67
- P/E Ratio
- PKE $39.97
- VALN N/A
- Revenue Growth
- PKE 15.45
- VALN N/A
- 52 Week Low
- PKE $11.96
- VALN $3.62
- 52 Week High
- PKE $16.96
- VALN $9.50
- Technical
- Relative Strength Index (RSI)
- PKE 46.79
- VALN 64.26
- Support Level
- PKE $14.36
- VALN $4.71
- Resistance Level
- PKE $15.46
- VALN $5.82
- Average True Range (ATR)
- PKE 0.57
- VALN 0.24
- MACD
- PKE 0.00
- VALN 0.10
- Stochastic Oscillator
- PKE 52.04
- VALN 72.22
About PKE Park Aerospace Corp.
Park Aerospace Corp designs develop and manufactures engineered, advanced composite materials and composite structures and assemblies and low-volume tooling for the aerospace markets and prototype tooling for such structures and assemblies. Geographically, the company derives a majority of revenue from North America and also has a presence in a company operates its business in Asia and Europe. It offers advanced composite Prepregs for Aircraft Structures and Interiors, Sigma Strut and Alpha Strut.
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.